Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbb8896db9a12a08f453c31440ff5488 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
filingDate |
2015-11-12^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-11-21^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ace822ab91b0f596e0d52981ee082d7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b50c1499d4ffaff108c67e24c30d65a5 |
publicationDate |
2017-11-21^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9822147-B2 |
titleOfInvention |
Methods of treating ophthalmic diseases using NPR-B agonists |
abstract |
Disclosed are novel compounds having NPR-B agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds. |
priorityDate |
2009-09-25^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |